A carregar...
Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
Epidermal growth factor receptor (EGFR) mutations are present in 20–40% of non-small cell lung cancers (NSCLCs). Brain metastasis (BM) is more common in EGFR-mutated NSCLC (25–45%) compared to EGFR wild-type (15–30%). First and second-generation tyrosine kinase inhibitors (TKIs), such as erlotinib a...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8182502/ https://ncbi.nlm.nih.gov/pubmed/34164215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-2019-rbmlc-04 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|